Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Zeus Resources Expands US Strategy for Casablanca Project | ASX 300 Spotlight
Basic Materials

Zeus Resources Expands US Strategy for Casablanca Project | ASX 300 Spotlight

Highlights,Zeus Resources taps Chris Dell to strengthen US engagement for Moroccan project,Appointment focuses on aligning with critical mineral frameworks in the US,Casablanca Project positioned as a non-China antimony supply source,Zeus Resources Ltd (A...

Krakatoa Advances Drilling Plans at Zopkhito Antimony-Gold Project | ASX 200
Basic Materials

Krakatoa Advances Drilling Plans at Zopkhito Antimony-Gold Project | ASX 200

Highlights,Krakatoa Resources finalises contracts for maiden drill program at Zopkhito,Two specialised rigs to target hard-to-reach and shallow areas,Project aims to support broader assessment and resource expansion,Krakatoa Resources Ltd (ASX:KTA), liste...

Giant Mining Extends Breccia Body at Majuba Hill Porphyry Project
Basic Materials

Giant Mining Extends Breccia Body at Majuba Hill Porphyry Project

Highlights,Breccia-hosted copper mineralisation confirmed at Majuba Hill,Drilling results highlight scale and continuity in Nevada copper zone,Phase two preparations underway with geological mapping complete,Giant Mining (CSE:BFG), active in the North Ame...

Prescient Therapeutics (ASX:PTX) Begins US Enrolment for PTX-100 Trial | ASX 300
Healthcare Stocks

Prescient Therapeutics (ASX:PTX) Begins US Enrolment for PTX-100 Trial | ASX 300

Highlights,Prescient Therapeutics launches first US site at VCU Massey for Phase 2a PTX-100 trial,The global study now includes patients across both US and Australia,PTX-100, a GGT-1 inhibitor, is the only compound of its class currently in clinical devel...

Krakatoa (ASX:KTA) Advances Zopkhito Antimony-Gold Drilling Plan | All Ordinaries
Basic Materials

Krakatoa (ASX:KTA) Advances Zopkhito Antimony-Gold Drilling Plan | All Ordinaries

Highlights,Krakatoa Resources prepares for maiden drilling campaign at Zopkhito Sb-Au Project in Georgia,Two specialised drill rigs mobilised; camp refurbishment and access track clearing completed,Geophysical surveys and foreign resource estimate expansi...

Lumos Diagnostics (ASX:LDX) Secures Major US Deal for FebriDx® | All Ordinaries
Healthcare Stocks

Lumos Diagnostics (ASX:LDX) Secures Major US Deal for FebriDx® | All Ordinaries

Highlights,Lumos Diagnostics signs exclusive multi-year US distribution deal with PHASE Scientific,Agreement includes milestone payments tied to regulatory progress for FebriDx®,CLIA waiver study nearing completion with submission expected in coming weeks...

Spenda (ASX:SPX) Drives B2B Fintech Evolution with Scalable Payment Platform | All Ordinaries
Financial Stocks

Spenda (ASX:SPX) Drives B2B Fintech Evolution with Scalable Payment Platform | All Ordinaries

Highlights,Spenda Ltd (ASX:SPX) delivers end-to-end B2B workflow automation to streamline business payments,Partnerships with major financial networks enhance Spenda’s service capabilities,Platform strategy expands reach across Australian SMEs through tar...

MA Financial Group (ASX:MAF) Sees Institutional and Individual Interest Grow Amid Allords Momentum
Financial Stocks

MA Financial Group (ASX:MAF) Sees Institutional and Individual Interest Grow Amid Allords Momentum

Highlights,Individual shareholders lead in ownership stakes,Institutional interest signals broader market attention,Insider reflect confidence in long-term direction,MA Financial Group (MAF) has gained attention following a notable increase in its market ...

Tryptamine Therapeutics Expands Psilocin Clinical Team Ahead of TRP-8803 Trial | All Ordinaries
Healthcare Stocks

Tryptamine Therapeutics Expands Psilocin Clinical Team Ahead of TRP-8803 Trial | All Ordinaries

Highlights,Tryptamine Therapeutics strengthens TRP-8803 program with two senior appointments,Australian-based team structure expected to enhance operational efficiency,Preparations underway for first-ever Binge Eating Disorder trial with Swinburne Univers...

ASX 200 Reacts as US Inflation Data Complicates Fed Rate Cut Outlook
Financial Stocks

ASX 200 Reacts as US Inflation Data Complicates Fed Rate Cut Outlook

Highlights,US CPI data shows modest monthly increase, with core inflation remaining elevated,Fed likely to delay rate cut decision amid ongoing price pressures,Energy, housing, and food drive June inflation growth while tariffs have mixed effect,Inflation...

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.